Role of endothelin in cardiovascular disease.
نویسندگان
چکیده
Endothelins are a family of peptides, which comprises endothelin-1 (ET-1), endothelin-2 (ET-2) and endothelin-3 (ET-3), each containing 21 amino-acids. ET-1 is a peptide secreted mostly by vascular endothelial cells, the predominant isoform expressed in vasculature and the most potent vasoconstrictor currently known. ET-1 also has inotropic, chemotactic and mitogenic properties. In addition, it influences salt and water homeostasis through its effects on the renin-angiotensin-aldosterone system (RAAS), vasopressin and atrial natriuretic peptide and stimulates the sympathetic nervous system. The overall action of endothelin is to increase blood pressure and vascular tone. Therefore, endothelin antagonists may play an important role in the treatment of cardiac, vascular and renal diseases associated with regional or systemic vasoconstriction and cell proliferation, such as essential hypertension, pulmonary hypertension, chronic heart failure and chronic renal failure. Long-term anti-endothelin therapy may improve symptoms and favourably alter the progression of heart failure. Endothelin appears to participate in induction and progression of sclerotic renal changes, leading to progression to end-stage renal disease. Anti-endothelin therapy might offer additional benefits in the prevention of progression of chronic renal failure in addition to the known benefits of RAAS inhibition. Clinical trials have demonstrated potentially important benefits of endothelin antagonists for patients with essential hypertension, pulmonary hypertension and heart failure. Further studies are necessary to determine the role of anti-endothelin therapy in the treatment of cardiovascular diseases and determine the different roles of selective receptor antagonism vs. mixed ET(A/B)-receptor antagonism in human diseases.
منابع مشابه
Interplay of Phosphorylated Apoptosis Repressor with CARD, Casein Kinase-2 and Reactive Oxygen Species in Regulating Endothelin-1–Induced Cardiomyocyte Hypertrophy
Objective(s): The role of the Apoptosis repressor with caspase recruitment domain (ARC) in apoptosis and in certain hypertrophic responses has been previously investigated, but its regulation of Endothelin-1 induced cardiac hypertrophy remains unknown. The present study discusses the inhibitory role of ARC against endothelin–induced hypertrophy. Results:In present study Endothelin treated car...
متن کاملThe Effect of Resistance Training on Plasma Levels of Endothelin 1 and Blood Pressure in Older Men
Introduction: Endothelin 1, which is secreted by vascular endothelial cells, has been identified as the most potent vasoconstrictor. The purpose of this study was to investigate the effect of a course of endothelin-1 plasma resistance training and its relationship with blood pressure in older men. Methods: In this quasi-experimental study, 30 elderly men (mean age 62.28 ± 8.08 years, height 17...
متن کاملNEP, ACE and Homologues: The Pathophysiology of Membrane Metalloproteases
The zinc metalloprotease, neprilysin (NEP), plays a role in the metabolism of cardiovascular, inflammatory and neuropeptides, including mitogenic peptides such as bombesin. In the cardiovascular system, NEP has a primary role in the inactivation of natriuretic peptides but also contributes to local metabolism of angiotensin, endothelins and bradykinin. Hence NEP is seen as a potential therapeut...
متن کاملEndothelin, the bad actor in the play: a marker or mediator of cardiovascular disease.
Endothelins (ETs) are a family of three endotheliumderived 21 amino acid vasoactive peptides (1–3). Of these, ET-1 possesses the most potent vasoconstrictive properties described to date (1,2). Although identified just over 10 years ago, there has already been a phenomenal amount of research conducted regarding the role of ET-1 in cardiovascular disorders (3–19). Endothelin-1 has been incrimina...
متن کاملDarusentan, a selective endothelin A receptor antagonist, for the oral treatment of resistant hypertension.
Resistant hypertension is defined as failure to lower blood pressure to target when a patient adheres to the maximum tolerated doses of three antihypertensive drugs including a diuretic. Notwithstanding the wide availability of several antihypertensive agents and the continued recommendation of dietary and lifestyle modifications, the prevalence of resistant hypertension remains high and is exp...
متن کاملThe importance of endothelin-1 for vascular dysfunction in cardiovascular disease.
Endothelin (ET)-1 is a potent vasoconstrictor peptide originally isolated from endothelial cells. Its production is stimulated in a variety of different cell types under the influence of risk factors for cardiovascular disease and during the development of cardiovascular disease. Based on these observations and the biological effects induced by ET-1, including profound vasoconstriction, pro-inf...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of the renin-angiotensin-aldosterone system : JRAAS
دوره 3 1 شماره
صفحات -
تاریخ انتشار 2002